Latest Commercialization News

Stellar Resources reports outstanding ore sorting results at its Heemskirk Tin Project, achieving a 2.4-fold increase in tin head grade and up to 95% tin recovery, promising significant cost savings and enhanced production potential.

Sky Metals has intersected significant visual tin mineralisation in the first diamond drill-hole at its Tallebung Tin Project, confirming the deposit remains open in all directions and setting the stage for a major resource expansion.

EMVision Medical Devices reports strong progress in clinical trials for its emu™ Bedside Scanner, backed by robust cash reserves and strategic non-dilutive funding. The company is poised to commence pivotal FDA validation trials, marking a key step toward commercialisation.

De.mem Limited has delivered its second highest quarterly cash receipts ever alongside positive operating cash flow for the December 2024 quarter, marking a milestone full-year cash flow turnaround and setting the stage for continued growth in 2025.

EBR Systems has signed a long-term lease for a 51,000 sq ft facility in Santa Clara, California, positioning itself for significant manufacturing expansion and future growth in wireless cardiac pacing technology.

Viva Energy delivered a slight increase in sales volumes for 4Q2024 and a record Commercial & Industrial segment performance, despite a disruptive refinery outage and challenging retail conditions. The company also secured key approvals for its Liberty Convenience acquisition, aiming for completion by March 2025.

Sprintex has locked in A$30 million in distribution agreements across the UK, Turkiye, and India, while advancing its innovative G25 Jet Blower launch, signaling a strong growth trajectory in energy-efficient technologies.

BrainChip Holdings reports a US$20 million cash balance and key defense contracts in its December 2024 quarterly update, underscoring its growing foothold in neuromorphic AI commercialization.

Dimerix Limited has inked a lucrative licensing agreement with Fuso Pharmaceutical for its kidney disease drug DMX-200 in Japan, while completing recruitment for its pivotal Phase 3 ACTION3 trial.

Vection Technologies has reported a milestone positive net cash flow in its traditionally weak quarter, driven by a 60% half-on-half revenue surge and strategic acquisition integration.

Gold Road Resources projects a significant production increase at Gruyere in 2025 and has initiated underground drilling to potentially extend mine life beyond 2032.

Terrain Minerals has launched Stage Two of its RC drilling campaign at the Wildflower Gold Project, expanding its exploration with two new targets and reinforcing optimism for a significant gold discovery. Concurrently, the Lort River Project drilling has intersected key bedrock conductors, marking progress in nickel-copper exploration.